Chinese Journal of Dermatology ›› 2023, Vol. 56 ›› Issue (11): 1074-1078.doi: 10.35541/cjd.20210158
• Reviews • Previous Articles Next Articles
Cao Meng, Hong Anlan, Wang Yan, Fang Fang
Received:
2021-02-24
Revised:
2021-07-27
Online:
2023-11-15
Published:
2023-11-03
Contact:
Wang Yan
E-mail:drwangyan@163.com
Supported by:
Cao Meng, Hong Anlan, Wang Yan, Fang Fang. Clinical progress in pediatric melanoma[J]. Chinese Journal of Dermatology, 2023, 56(11): 1074-1078.doi:10.35541/cjd.20210158
[1] | Carrera C, Scope A, Dusza SW, et al. Clinical and dermoscopic characterization of pediatric and adolescent melanomas: multicenter study of 52 cases[J]. J Am Acad Dermatol, 2018,78(2):278⁃288. doi: 10.1016/j.jaad.2017.09.065. |
[2] | Cordoro KM, Gupta D, Frieden IJ, et al. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children[J]. J Am Acad Dermatol, 2013,68(6):913⁃925. doi: 10.1016/j.jaad.2012.12.953. |
[3] | Sreeraman Kumar R, Messina JL, Reed D, et al. Pediatric melanoma and atypical melanocytic neoplasms[J]. Cancer Treat Res, 2016,167:331⁃369. doi: 10.1007/978⁃3⁃319⁃22539⁃5_15. |
[4] | Kaste SC. Imaging of pediatric cutaneous melanoma[J]. Pediatr Radiol, 2019,49(11):1476⁃1487. doi: 10.1007/s00247⁃019⁃04374⁃9. |
[5] | Bahrami A, Barnhill RL. Pathology and genomics of pediatric melanoma: a critical reexamination and new insights[J]. Pediatr Blood Cancer, 2018,65(2):10.1002/pbc.26792. doi: 10. 1002/pbc.26792. |
[6] | Kinsler VA, O′Hare P, Bulstrode N, et al. Melanoma in congenital melanocytic naevi[J]. Br J Dermatol, 2017,176(5):1131⁃1143. doi: 10.1111/bjd.15301. |
[7] | Al⁃Himdani S, Naderi N, Whitaker IS, et al. An 18⁃year study of malignant melanoma in childhood and adolescence[J]. Plast Reconstr Surg Glob Open, 2019,7(8):e2338. doi: 10.1097/GOX. 0000000000002338. |
[8] | Saiyed FK, Hamilton EC, Austin MT. Pediatric melanoma: incidence, treatment, and prognosis[J]. Pediatric Health Med Ther, 2017,8:39⁃45. doi: 10.2147/PHMT.S115534. |
[9] | Chrysouli K, Tsakanikos M, Stamataki S. A case report of melanoma as acute mastoiditis in a 10⁃month⁃old female child[J]. Case Rep Otolaryngol, 2019,2019:9641945. doi: 10.1155/2019/9641945. |
[10] | Lim Y, Shin HT, Choi Y, et al. Evolutionary processes of melanomas from giant congenital melanocytic nevi[J]. Pigment Cell Melanoma Res, 2020,33(2):318⁃325. doi: 10.1111/pcmr. 12829. |
[11] | Motaparthi K, Kim J, Andea AA, et al. TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis[J]. J Cutan Pathol, 2020,47(8):710⁃719. doi: 10.1111/cup.13691. |
[12] | Goldstein AM, Stidd KC, Yang XR, et al. Pediatric melanoma in melanoma⁃prone families[J]. Cancer, 2018,124(18):3715⁃3723. doi: 10.1002/cncr.31641. |
[13] | Okamura R, Boichard A, Kato S, et al. Analysis of NTRK alterations in pan⁃cancer adult and pediatric malignancies: implications for NTRK⁃Targeted therapeutics[J]. JCO Precis Oncol, 2018,2018:PO.18.00183. doi: 10.1200/PO.18.00183. |
[14] | Mitkov M, Chrest M, Diehl NN, et al. Pediatric melanomas often mimic benign skin lesions: a retrospective study[J]. J Am Acad Dermatol, 2016,75(4):706⁃711.e4. doi: 10.1016/j.jaad.2016.05. 015. |
[15] | Merkel EA, Mohan LS, Shi K, et al. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis[J]. Lancet Child Adolesc Health, 2019,3(9):646⁃654. doi: 10.1016/S2352⁃4642(19)30116⁃6. |
[16] | Kalani N, Guidry JA, Farahi JM, et al. Pediatric melanoma: characterizing 256 cases from the colorado central cancer registry[J]. Pediatr Dermatol, 2019,36(2):219⁃222. doi: 10. 1111/pde.13747. |
[17] | Kim J, Sun Z, Gulack BC, et al. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma[J]. J Pediatr Surg, 2016,51(6):986⁃990. doi: 10.1016/j.jpedsurg.2016.02.067. |
[18] | Afanasiev OK, Tu JH, Chu DH, et al. Characteristics of melanoma in white and nonwhite children, adolescents, and young adults: analysis of a pediatric melanoma institutional registry, 1995-2018[J]. Pediatr Dermatol, 2019,36(4):448⁃454. doi: 10.1111/pde.13836. |
[19] | Yan Y, Huang Y, Wang Y, et al. The first Chinese case of pediatric subungual melanoma: a case report and literature review[J]. Dermatol Ther, 2020,33(6):e13918. doi: 10.1111/dth.13918. |
[20] | Ulloa⁃Padilla JP, Khararjian A, Choi CJ. Cutaneous eyelid melanoma in an African American child[J]. Orbit, 2020:1⁃4. doi: 10.1080/01676830.2020.1799419. |
[21] | Lorimer PD, White RL, Walsh K, et al. Pediatric and adolescent melanoma: a national cancer data base update[J]. Ann Surg Oncol, 2016,23(12):4058⁃4066. doi: 10.1245/s10434⁃016⁃5349⁃2. |
[22] | Miranda SG, Kashani⁃Sabet M, Zedek D, et al. Cutaneous Spitzoid melanoma in a very young girl of Asian descent[J]. BMJ Case Rep, 2011,2011:bcr0920103343 doi: 10.1136/bcr.09. 2010.3343. |
[23] | Pillay K, Adams S, Vandermaesen L, et al. Acellular dermal matrix: treating periocular melanoma in a patient with xeroderma pigmentosa[J]. Plast Reconstr Surg Glob Open, 2017,5(8):e1442. doi: 10.1097/GOX.0000000000001442. |
[24] | Pfau D, Tamaki A, Hoppe KR, et al. Sentinel node biopsy in young patients with atypical melanocytic tumors of the head and neck[J]. OTO Open, 2019,3(2):2473974X19850752. doi: 10. 1177/2473974X19850752. |
[25] | Kim JY, Choi JE, Ahn HH, et al. A case of spitzoid melanoma with lymph node metastasis in a child[J]. J Korean Med Sci, 2012,27(4):454⁃457. doi: 10.3346/jkms.2012.27.4.454. |
[26] | Navid F, Herzog CE, Sandoval J, et al. Feasibility of pegylated interferon in children and young adults with resected high⁃risk melanoma[J]. Pediatr Blood Cancer, 2016,63(7):1207⁃1213. doi: 10.1002/pbc.25983. |
[27] | Mun SJ, Jung HY, Frolova A, et al. Malignant mucosal melanoma in the olfactory cleft of a 10⁃year⁃old child[J]. Auris Nasus Larynx, 2013,40(2):235⁃238. doi: 10.1016/j.anl.2012.05. 001. |
[28] | Marjanska A, Galazka P, Marjanski M, et al. Efficacy and toxicity of pembrolizumab in pediatric metastatic recurrent melanoma[J]. Anticancer Res, 2019,39(7):3945⁃3947. doi: 10. 21873/anticanres.13547. |
[29] | Baniak N, Podberezin M, Kanthan SC, et al. Primary pulmonary/pleural melanoma in a 13 year⁃old presenting as pleural effusion[J]. Pathol Res Pract, 2017,213(2):161⁃164. doi: 10.1016/j.prp.2016.11.013. |
[30] | Davis KL, Fox E, Merchant MS, et al. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open⁃label, single⁃arm, phase 1⁃2 trial[J]. Lancet Oncol, 2020,21(4):541⁃550. doi: 10.1016/S1470⁃2045(20)30023⁃1. |
[31] | MarjaŃska A, Drogosiewicz M, Dembowska⁃BagiŃska B, et al. Nivolumab for the treatment of advanced pediatric malignancies[J]. Anticancer Res, 2020,40(12):7095⁃7100. doi: 10.21873/anticanres.14738. |
[32] | Geoerger B, Kang HJ, Yalon⁃Oren M, et al. Pembrolizumab in paediatric patients with advanced melanoma or a PD⁃L1⁃positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE⁃051): interim analysis of an open⁃label, single⁃arm, phase 1⁃2 trial[J]. Lancet Oncol, 2020,21(1):121⁃133. doi: 10.1016/S1470⁃2045(19)30671⁃0. |
[33] | Chisholm JC, Suvada J, Dunkel IJ, et al. BRIM⁃P: a phase I, open⁃label, multicenter, dose⁃escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation⁃positive melanoma[J]. Pediatr Blood Cancer, 2018,65(5):e26947. doi: 10.1002/pbc.26947. |
[34] | Subbiah V, Sen S, Hess KR, et al. Phase I study of the braf inhibitor vemurafenib in combination with the mammalian target of rapamycin inhibitor everolimus in patients with BRAF⁃mutated malignancies[J]. JCO Precis Oncol, 2018,2:PO.18. 00189. doi: 10.1200/PO.18.00189. |
[35] | Endo C, Johnson TA, Morino R, et al. Genome⁃wide association study in Japanese females identifies fifteen novel skin⁃related trait associations[J]. Sci Rep, 2018,8(1):8974. doi: 10.1038/s41598⁃018⁃27145⁃2. |
[36] | Newman S, Fan L, Pribnow A, et al. Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas[J]. Nat Med, 2019,25(4):597⁃602. doi: 10.1038/s41591⁃019⁃0373⁃y. |
[37] | Ipenburg NA, Lo SN, Vilain RE, et al. The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: a retrospective cohort study[J]. J Am Acad Dermatol, 2020,82(4):910⁃919. doi: 10.1016/j.jaad.2019.10.065. |
[38] | Pincheira MA, Bacharier LB, Castro⁃Rodriguez JA. Correction to: efficacy of macrolides on acute asthma or wheezing exacerbations in children with recurrent wheezing: a systematic review and meta⁃analysis[J]. Paediatr Drugs, 2020,22(2):241. doi: 10.1007/s40272⁃020⁃00390⁃7. |
[1] | Dong Dong, Liu Tianyi. Cell metabolism and metastasis of cutaneous malignant melanoma [J]. Chinese Journal of Dermatology, 2023, 56(9): 878-881. |
[2] | Liu Yuanxiang, Liang Yuan, Zhao Xinrong, Sun Yujuan, Ma Lin, Xu Zigang. Janus kinase inhibitors for the treatment of five children with severe alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 849-852. |
[3] | Wang Shan, Wang Xingyu, Shu Hong, Zhang Bin, Shi Hang, Yang Huan, Qian Qiufang, Ma Hongyan, Liang Yuan, Zhao Mutong, Shen Chunping, Jiao Lei, Tian Jing, Wang Yang, Gu Ying, Sun Jing, Liu Ying, Li Ping, Wang Hua, Ma Lin. Efficacy of crisaborole ointment in clinical symptom relief in the early stage of childhood atopic dermatitis and in symptom improvement in the remission stage: a multicenter clinical study [J]. Chinese Journal of Dermatology, 2023, 56(9): 815-821. |
[4] | Shen Chunping, Li Ping, Luo Xiaoyan, Liang Yuan, Liu Ying, Zhao Mutong, Wang Shan, Tian Jing, Jiao Lei, Wang Yang, Luo Zhen, Yu Shijuan, Fang Xiao, Wang Hua, Ma Lin . Efficacy of daily use of a test emollient combined with topical glucocorticoids applied at the weekend for delaying the recurrence of atopic dermatitis in children during the maintenance period: a randomized, blank-controlled, multicenter clinical study [J]. Chinese Journal of Dermatology, 2023, 56(8): 756-762. |
[5] | Yuan Xingang, Ni Sili, Zhang Jian, Luo Xiaoyan, Wang Hua. Improving diagnosis and treatment of melanocytic nevi in children: an urgent need [J]. Chinese Journal of Dermatology, 2023, 56(8): 782-786. |
[6] | Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723. |
[7] | Sun Linbo, Xu Jiaosheng. Curry-Jones syndrome: the first case reported in China [J]. Chinese Journal of Dermatology, 2023, 56(7): 626-629. |
[8] | Guo Yanyang, Hai Luming, Zhu Zhenlai, Yan Dong, Zhu Guannan, Wang Gang, Fu Meng. Analysis of pathogenic fungi causing tinea capitis: a single-center retrospective study [J]. Chinese Journal of Dermatology, 2023, 56(6): 531-533. |
[9] | Zhou Yabin, Xiao Yuanyuan, Chao Jinjing, Ma Lin. Comparison of oral terbinafine versus itraconazole in the treatment of tinea capitis in children [J]. Chinese Journal of Dermatology, 2023, 56(5): 438-440. |
[10] | Zhang Congcong, Chen Hao. Spitzoid melanocytic tumors [J]. Chinese Journal of Dermatology, 2023, 56(5): 463-467. |
[11] | Ren Faliang, Wang Hua, Xiao Yizhu. Clinical characteristics of 57 cases of clear cell papulosis [J]. Chinese Journal of Dermatology, 2023, 56(4): 309-312. |
[12] | Sun Peiwen, Wang Le, Wang Hongsheng, Yan Liangbin, Yu Meiwen. Epidemiological characteristics of leprosy in China from 2016 to 2020 [J]. Chinese Journal of Dermatology, 2023, 56(3): 204-209. |
[13] | Wang Yuanli, Liu Ling, Sun Zhongbin, Li Kai. Analysis of 141 cases clinically misdiagnosed as melanoma [J]. Chinese Journal of Dermatology, 2023, 56(3): 244-246. |
[14] | Yang Yongting, Li Tingting, Kang Xiaojing. Biomarkers related to the treatment of melanoma with immune checkpoint inhibitors [J]. Chinese Journal of Dermatology, 2023, 56(3): 278-283. |
[15] | Deng Wei, Zhang Gaolei, Chen Jianyou, Zhang Sheng, Jiang Lixiao, Liu Xiaoyan, Su Wei. Skin manifestations of 61 children with coronavirus disease 19 [J]. Chinese Journal of Dermatology, 2023, 0(3): 20220910-e20220910. |
|